
“Looking for the very highest quality products and the consistency of a high-tech pharmaceuticals operation? Vida expects to file its licensing application before the end of April, a schedule that should allow it to have the necessary license in hand by the third quarter of this year. In the meantime, the company is raising $1.5 million at $.25 per share. That represents a market value of only $6 million for a company that now owns a 315,000-square-foot production plant with a replacement value estimated at $30 million. Personally, I think this will turn out to be an extraordinary investment. In less than a year’s time, this $.25 financing round is going to look extremely cheap.”
Related posts:
Another Hypocritical Leftist Caught with His Hand in the Tax-Haven Cookie Jar
New Jersey woman busted for showing breasts, middle fingers to surveillance camera
Bitcoin Payment Processor BIPS Attacked, Over $1m Stolen
Will Trump Make a Deal with the CIA on JFK Records?
The Carlos Miller Case: Jury Says ‘Not Guilty’
Sophisticated U.S. Arms Flowing to Jihadists
They Hate Us for Our Freedom
Hackers steal $1.2m of bitcoins from a supposedly secure wallet service
Orwell Reigns Over Raw Milk Trial
Before Sir John Marks Templeton, there was Cleveland Ferguson
Dark Wallet Meeting - interview with Wendell Davis
Why Is the U.S. Government Funding Islamic Terrorists Who Are Killing Christians?
Drone Hunting Season to Begin in Colorado
Responding to Scandals and Corruption, the IRS Rewards Itself with Giant Bonuses
Russian report on chemical attack indicates similarity with rebel-made weapons